These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2502955)

  • 1. Rioprostil, a new prostaglandin E1 analogue does not affect glucose homeostasis in healthy volunteers.
    Eichler HG; Korn A; Businger JA; Waldhäusl WK
    Arch Int Pharmacodyn Ther; 1989; 298():288-92. PubMed ID: 2502955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
    Baunack AR; Froese G; Demol P; Wargenau M; Ruoff HJ; Weihrauch TR
    Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
    Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
    Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
    Dammann HG; Rehner M; Walter TA; Müller P; Simon B
    Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rioprostil, a methyl-prostaglandin E1, on plasma level and renal excretion of beta-acetyldigoxin.
    Demol P; Wingender W; Kuhlmann J
    Scand J Gastroenterol Suppl; 1989; 164():68-71; discussion 71-2. PubMed ID: 2510284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rioprostil, a methylprostaglandin E1 analog, on basal and stimulated plasma pancreatic hormone levels in man.
    Segers O; Somers G
    Dig Dis Sci; 1990 Jan; 35(1):20-6. PubMed ID: 2104796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rioprostil on the postprandial glucose, GIP, insulin and gastrin levels in volunteers.
    Demol P; Wingender W
    Scand J Gastroenterol Suppl; 1989; 164():112-7. PubMed ID: 2510253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the prostaglandin E1 analogue Rioprostil on the human gastric mucosa.
    Svendsen LB; Stener Jørgensen F; Hart Hansen O; Johansen A; Horn T; Larsen JK
    Digestion; 1987; 37(1):29-34. PubMed ID: 3111919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rioprostil, an oral prostaglandin E1 analogue, on lower oesophageal sphincter pressure and on the motility of the distal oesophagus in healthy volunteers.
    Baunack AR; Demol P; Froese G; Kuhlmann J; Weihrauch TR
    Scand J Gastroenterol Suppl; 1989; 164():120-5; discussion 125-6. PubMed ID: 2510255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
    Cohen A; Tolman KG; Lewis GP; Brown S; van Horn A; McCormack GH; Simon DM
    Scand J Gastroenterol Suppl; 1989; 164():81-90; discussion 90-1. PubMed ID: 2510286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
    Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
    Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interactions between theophylline and rioprostil.
    de Lauture D; Rey E; d'Athis P; Richard MO; Paccaly D; Prunieras F; Strauch G; Olive G
    Scand J Gastroenterol Suppl; 1989; 164():63-6; discussion 67. PubMed ID: 2510283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rioprostil on aspirin-induced gastrointestinal mucosal changes in normal volunteers.
    Tolman KG; Detweiler MK; Harrison CA; Rollins DE; Simon DA; Brady C; McCormack GH; Bryant EC
    J Clin Pharmacol; 1988 Jan; 28(1):76-80. PubMed ID: 3127431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents.
    Thijssen HH; Hamulyàk K
    Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
    Demol P; Wingender W; Weihrauch TR; Graefe KH
    Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of chronic rioprostil treatment on gastric endocrine function.
    Koop H; Schwarting H; Eckel U; Wagenknecht J; Hallfeldt U; Arnold R
    Scand J Gastroenterol Suppl; 1989; 164():104-10; discussion 110-1. PubMed ID: 2573147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rioprostil, a new prostaglandin E1, prevents cyclosporin A-induced damage to endocrine and exocrine pancreas.
    Müller M; Degenhardt H; Bergmann K; Coone H; Löhr M; Klöppel G; Goebell H
    Scand J Gastroenterol Suppl; 1989; 164():35-41. PubMed ID: 2510278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
    Simon B; Dammann HG; Müller P
    Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.